Kangmei Pharmaceutical Co., Ltd. (SHA:600518)
1.940
-0.010 (-0.51%)
Jun 6, 2025, 2:45 PM CST
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2016 - 2018 |
---|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2016 - 2018 |
Chinese Medicine | 2.33B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Chinese Medicine Growth | 22.33% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Western Medicine | 1.44B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Western Medicine Growth | 1.85% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Health Food and Food | 502.79M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Health Food and Food Growth | 54.90% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Property Rental and Sale and Others | 447.59M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Property Rental and Sale and Others Growth | 11.06% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Medical Instruments | 103.18M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Medical Instruments Growth | -8.14% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other Business | 47.30M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other Business Growth | 149.66% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Pharmaceutical | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Pharmaceutical Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2016 - 2018 |
---|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2016 - 2018 |
China | 4.87B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
China Growth | 16.60% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Overseas | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|